The makers of a homeopathic capsaicin nasal spray are presenting a poster featuring “real-world patient case series analysis supporting the use of intranasal capsaicin as an effective rapid treatment for severe headache and migraine pain” at the 2014 American Academy of Neurology (AAN) Annual Meeting. VR1, Inc. recently launched an intranasal capsaicin product, marketed as Ausanil, in the US.
The poster presents the results of a survey of 18 patients with a variety of headache types who reported “dissatisfaction with their treatment regimen that included several different commonly used prescription and non-prescription medications for headaches.” According to VR1, 13 of the patients reported complete pain relief, and “Most remaining patients also reported experiencing some pain relief.”
“All 18 patients,” the company said,” reported experiencing the local adverse event of the nasal sting, lasting between two to 10 minutes, and lacrimation.”
VR1 founder Anjan Chatterjee said, “By depleting CGRP, intranasal capsaicin is able to specifically target the source of the headache pain. These results emphasize the potential that intranasal capsaicin may offer in terms of rapid pain relief to severe headache and migraine sufferers who are in need of new treatment options.”
Hi Tech Pharmacal, which was recently acquired by Akorn, markets a homeopathic capsaicin nasal spray called Sinus Buster for the treatment of sinus congestion. The company recently settled a class action lawsuit that claimed that Hi-Tech misrepresented the efficacy of Sinus Buster products.
Read the VR1 press release.
